| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Garlic | 11 | 2003 | 13 | 1.730 |
Why?
|
| Mouth Neoplasms | 14 | 2003 | 732 | 1.530 |
Why?
|
| CA-19-9 Antigen | 4 | 2023 | 155 | 0.980 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 12 | 2003 | 129 | 0.940 |
Why?
|
| Cysteine | 5 | 2003 | 214 | 0.930 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1819 | 0.830 |
Why?
|
| Histone Deacetylases | 10 | 2013 | 366 | 0.770 |
Why?
|
| Tenascin | 2 | 2017 | 56 | 0.680 |
Why?
|
| Plant Extracts | 8 | 2003 | 226 | 0.650 |
Why?
|
| Trans-Activators | 18 | 2013 | 1655 | 0.640 |
Why?
|
| Phytotherapy | 4 | 2003 | 113 | 0.630 |
Why?
|
| Plants, Medicinal | 5 | 2001 | 52 | 0.620 |
Why?
|
| Lipoproteins | 2 | 2017 | 231 | 0.610 |
Why?
|
| Carcinogens | 9 | 2003 | 391 | 0.590 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 5235 | 0.580 |
Why?
|
| Lipid Peroxidation | 13 | 2002 | 161 | 0.560 |
Why?
|
| Cricetinae | 14 | 2003 | 792 | 0.560 |
Why?
|
| Mesocricetus | 13 | 2003 | 119 | 0.550 |
Why?
|
| Repressor Proteins | 10 | 2013 | 1726 | 0.520 |
Why?
|
| Cheek | 9 | 2003 | 57 | 0.430 |
Why?
|
| Carcinoma, Squamous Cell | 11 | 2003 | 5567 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1441 | 0.430 |
Why?
|
| Glutathione | 10 | 2002 | 377 | 0.430 |
Why?
|
| Keratins | 2 | 2003 | 352 | 0.390 |
Why?
|
| Cyclin D1 | 2 | 2004 | 589 | 0.390 |
Why?
|
| Glutathione Transferase | 12 | 2004 | 368 | 0.380 |
Why?
|
| Glutathione Peroxidase | 11 | 2002 | 64 | 0.360 |
Why?
|
| Transcription Factors | 15 | 2013 | 5493 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 323 | 0.330 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2003 | 896 | 0.300 |
Why?
|
| PAX5 Transcription Factor | 1 | 2007 | 47 | 0.290 |
Why?
|
| Breast Neoplasms | 18 | 2022 | 16193 | 0.280 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2006 | 237 | 0.250 |
Why?
|
| Chemoprevention | 2 | 2003 | 251 | 0.250 |
Why?
|
| Antioxidants | 5 | 2002 | 522 | 0.240 |
Why?
|
| Serine | 3 | 2006 | 396 | 0.240 |
Why?
|
| Biomarkers, Tumor | 8 | 2023 | 10698 | 0.240 |
Why?
|
| Receptors, Estrogen | 6 | 2008 | 2264 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2022 | 9083 | 0.230 |
Why?
|
| Lymphoma, B-Cell | 2 | 2007 | 935 | 0.220 |
Why?
|
| Mammary Glands, Animal | 4 | 2010 | 635 | 0.220 |
Why?
|
| Apoptosis | 4 | 2004 | 7853 | 0.210 |
Why?
|
| Cell Movement | 1 | 2010 | 2502 | 0.210 |
Why?
|
| Anticarcinogenic Agents | 2 | 2002 | 371 | 0.210 |
Why?
|
| Endometrium | 1 | 2006 | 469 | 0.210 |
Why?
|
| Sulfinic Acids | 1 | 2002 | 2 | 0.210 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 5 | 2002 | 18 | 0.200 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 342 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2014 | 1884 | 0.190 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2003 | 374 | 0.190 |
Why?
|
| Blotting, Western | 7 | 2010 | 3648 | 0.190 |
Why?
|
| Tongue | 1 | 2001 | 85 | 0.190 |
Why?
|
| Animals | 31 | 2014 | 62801 | 0.180 |
Why?
|
| Up-Regulation | 9 | 2010 | 2466 | 0.180 |
Why?
|
| Wnt1 Protein | 2 | 2010 | 102 | 0.180 |
Why?
|
| Endometrial Neoplasms | 3 | 2006 | 1380 | 0.180 |
Why?
|
| Transcriptional Activation | 6 | 2007 | 1147 | 0.170 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2007 | 1735 | 0.170 |
Why?
|
| Gene Expression | 3 | 2006 | 3679 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 6 | 2006 | 744 | 0.170 |
Why?
|
| Pancreatitis, Chronic | 2 | 2017 | 127 | 0.170 |
Why?
|
| Signal Transduction | 11 | 2014 | 12206 | 0.160 |
Why?
|
| Tongue Neoplasms | 1 | 2001 | 252 | 0.160 |
Why?
|
| Co-Repressor Proteins | 8 | 2008 | 119 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 7 | 2013 | 3246 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2003 | 615 | 0.150 |
Why?
|
| Liver | 4 | 2002 | 3123 | 0.150 |
Why?
|
| Eye Proteins | 2 | 2010 | 278 | 0.150 |
Why?
|
| Estrogens | 4 | 2006 | 845 | 0.140 |
Why?
|
| Cell Line, Tumor | 16 | 2022 | 14875 | 0.140 |
Why?
|
| Adenocarcinoma | 3 | 2010 | 7936 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2017 | 404 | 0.140 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 3415 | 0.130 |
Why?
|
| Blotting, Northern | 3 | 2007 | 736 | 0.130 |
Why?
|
| RNA, Messenger | 7 | 2010 | 6484 | 0.130 |
Why?
|
| Estrogen Receptor beta | 3 | 2005 | 168 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2022 | 1004 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 724 | 0.130 |
Why?
|
| Transfection | 3 | 2007 | 3169 | 0.130 |
Why?
|
| Cholestasis | 1 | 2017 | 206 | 0.120 |
Why?
|
| Antineoplastic Agents | 4 | 2002 | 14679 | 0.120 |
Why?
|
| Mice, Transgenic | 6 | 2010 | 4373 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 3653 | 0.120 |
Why?
|
| Cell Shape | 1 | 2004 | 129 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 879 | 0.120 |
Why?
|
| p21-Activated Kinases | 5 | 2006 | 131 | 0.120 |
Why?
|
| ROC Curve | 1 | 2017 | 1236 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 6 | 2008 | 5834 | 0.110 |
Why?
|
| Humans | 38 | 2023 | 270825 | 0.110 |
Why?
|
| Male | 23 | 2017 | 128398 | 0.110 |
Why?
|
| Receptors, Endothelin | 1 | 2013 | 25 | 0.110 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 45 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 2010 | 1135 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2014 | 215 | 0.110 |
Why?
|
| Mouth Mucosa | 3 | 2003 | 225 | 0.110 |
Why?
|
| HeLa Cells | 5 | 2013 | 1719 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2002 | 208 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1372 | 0.100 |
Why?
|
| Acute Disease | 1 | 2017 | 2512 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 2489 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2017 | 6025 | 0.100 |
Why?
|
| Phosphorylation | 6 | 2006 | 4990 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 1572 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 1132 | 0.100 |
Why?
|
| Gene Expression Regulation | 4 | 2013 | 4186 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 5 | 2006 | 1502 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 327 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2010 | 145 | 0.090 |
Why?
|
| Plasmids | 3 | 2007 | 952 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2014 | 523 | 0.090 |
Why?
|
| RNA, Small Interfering | 5 | 2010 | 2214 | 0.080 |
Why?
|
| Breast | 2 | 2022 | 1379 | 0.080 |
Why?
|
| Cytoplasm | 3 | 2006 | 718 | 0.080 |
Why?
|
| Precipitin Tests | 3 | 2004 | 362 | 0.080 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 1329 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2007 | 512 | 0.080 |
Why?
|
| Tripartite Motif Proteins | 3 | 2014 | 51 | 0.080 |
Why?
|
| Dyneins | 2 | 2005 | 33 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 1076 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2006 | 7810 | 0.080 |
Why?
|
| Neoplasm Proteins | 3 | 2006 | 3349 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 5485 | 0.070 |
Why?
|
| Histone Deacetylase 1 | 1 | 2007 | 63 | 0.070 |
Why?
|
| Rhodopsin | 1 | 2007 | 69 | 0.070 |
Why?
|
| Cell Division | 4 | 2004 | 2716 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1538 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 13977 | 0.070 |
Why?
|
| Mice | 11 | 2013 | 36026 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 5163 | 0.070 |
Why?
|
| Female | 19 | 2022 | 148456 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 557 | 0.070 |
Why?
|
| Time Factors | 4 | 2004 | 13103 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 5184 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2007 | 643 | 0.070 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2006 | 117 | 0.070 |
Why?
|
| Epithelium | 2 | 2014 | 805 | 0.060 |
Why?
|
| Plant Leaves | 3 | 2000 | 60 | 0.060 |
Why?
|
| Rats, Wistar | 3 | 2001 | 601 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2017 | 9430 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2009 | 2109 | 0.060 |
Why?
|
| Microtubules | 1 | 2005 | 330 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2000 | 55 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2003 | 259 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2022 | 4190 | 0.050 |
Why?
|
| Epithelial Cells | 3 | 2022 | 1887 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 686 | 0.050 |
Why?
|
| Densitometry | 1 | 2002 | 52 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2002 | 91 | 0.050 |
Why?
|
| India | 1 | 2003 | 314 | 0.050 |
Why?
|
| Benz(a)Anthracenes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Erythrocytes | 2 | 2001 | 358 | 0.050 |
Why?
|
| Protein Binding | 3 | 2004 | 3536 | 0.050 |
Why?
|
| S Phase | 1 | 2003 | 290 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 658 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 532 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 704 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2002 | 100 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 672 | 0.050 |
Why?
|
| Disulfides | 1 | 2002 | 111 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 1152 | 0.050 |
Why?
|
| Protective Agents | 1 | 2002 | 51 | 0.050 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2001 | 42 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 30940 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2003 | 956 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 916 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2014 | 577 | 0.050 |
Why?
|
| Coffee | 1 | 2001 | 33 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 191 | 0.050 |
Why?
|
| Catalase | 1 | 2001 | 75 | 0.050 |
Why?
|
| Carotenoids | 1 | 2001 | 101 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 499 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2006 | 1742 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2004 | 2152 | 0.050 |
Why?
|
| Glycerides | 1 | 2000 | 12 | 0.040 |
Why?
|
| Random Allocation | 1 | 2002 | 747 | 0.040 |
Why?
|
| Plants | 1 | 2000 | 63 | 0.040 |
Why?
|
| Terpenes | 1 | 2000 | 40 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1229 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2005 | 181 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2001 | 270 | 0.040 |
Why?
|
| Phospholipids | 1 | 2000 | 171 | 0.040 |
Why?
|
| RNA | 1 | 2004 | 1067 | 0.040 |
Why?
|
| Aged | 5 | 2017 | 73188 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 641 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 791 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2007 | 7465 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 3073 | 0.040 |
Why?
|
| Acetylation | 2 | 2013 | 519 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2006 | 1834 | 0.040 |
Why?
|
| Middle Aged | 5 | 2017 | 90030 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 908 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 1529 | 0.040 |
Why?
|
| Rats | 3 | 2001 | 6639 | 0.040 |
Why?
|
| Chromatin | 3 | 2010 | 1050 | 0.040 |
Why?
|
| Estradiol | 3 | 2006 | 885 | 0.040 |
Why?
|
| Histones | 1 | 2004 | 1513 | 0.040 |
Why?
|
| Mammary Glands, Human | 2 | 2010 | 185 | 0.030 |
Why?
|
| Tamoxifen | 3 | 2006 | 907 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2003 | 1584 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2000 | 2314 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1547 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2004 | 2123 | 0.030 |
Why?
|
| Cell Line | 1 | 2003 | 5435 | 0.030 |
Why?
|
| Disease Progression | 2 | 2006 | 6892 | 0.030 |
Why?
|
| Proteins | 1 | 2003 | 2047 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2008 | 487 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2000 | 1066 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2004 | 132 | 0.030 |
Why?
|
| Base Sequence | 3 | 2006 | 5494 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2000 | 1157 | 0.030 |
Why?
|
| Cryptochromes | 1 | 2013 | 14 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2013 | 122 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2003 | 2648 | 0.030 |
Why?
|
| Photoperiod | 1 | 2013 | 24 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2013 | 33 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 52 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 124 | 0.030 |
Why?
|
| Luciferases | 2 | 2004 | 462 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 4519 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 80 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 194 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4774 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 347 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 233 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2013 | 5835 | 0.020 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 553 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 886 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 10350 | 0.020 |
Why?
|
| Binding Sites | 2 | 2006 | 2306 | 0.020 |
Why?
|
| Methylnitronitrosoguanidine | 2 | 2000 | 14 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2008 | 7302 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2008 | 4360 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 1725 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2003 | 33821 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2093 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 758 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1473 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 718 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 474 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 336 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2010 | 39679 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2000 | 2316 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 6784 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2008 | 183 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2007 | 456 | 0.020 |
Why?
|
| Osteosarcoma | 2 | 2004 | 948 | 0.020 |
Why?
|
| ErbB Receptors | 2 | 2005 | 2379 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 690 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 119 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 759 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2006 | 46 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1084 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1214 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2006 | 154 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 200 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2005 | 67 | 0.020 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2005 | 6 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 342 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 7220 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2008 | 1045 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2006 | 162 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 213 | 0.020 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2008 | 329 | 0.020 |
Why?
|
| COS Cells | 1 | 2005 | 422 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2005 | 112 | 0.020 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 33 | 0.020 |
Why?
|
| Tubulin | 1 | 2005 | 203 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 441 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 349 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 2004 | 14 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 271 | 0.010 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2004 | 51 | 0.010 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2008 | 497 | 0.010 |
Why?
|
| Gene Library | 1 | 2005 | 357 | 0.010 |
Why?
|
| Azo Compounds | 1 | 2003 | 15 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2005 | 354 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 269 | 0.010 |
Why?
|
| Chromans | 1 | 2003 | 29 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2006 | 503 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 614 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 251 | 0.010 |
Why?
|
| Prognosis | 2 | 2013 | 22452 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 1567 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 236 | 0.010 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 153 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2004 | 335 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 711 | 0.010 |
Why?
|
| Mutation | 3 | 2009 | 15859 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 1460 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 783 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 840 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 1061 | 0.010 |
Why?
|
| Trastuzumab | 1 | 2003 | 736 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 1961 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 1508 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2006 | 1645 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2003 | 499 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 4641 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2004 | 853 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 585 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 1666 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 3081 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 15852 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 3086 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5780 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 10250 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 5103 | 0.010 |
Why?
|
| Stomach | 1 | 2000 | 406 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 5325 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3067 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 2561 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 2617 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2000 | 659 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 3072 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2471 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 6464 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2003 | 3394 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 2667 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 81540 | 0.000 |
Why?
|